Gagnon Securities’s Rein Therapeutics, Inc. Common Stock RNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100K | Hold |
71,745
| – | – | 0.02% | 86 |
|
|
2025
Q1 | $127K | Hold |
71,745
| – | – | 0.03% | 93 |
|
|
2024
Q4 | $165K | Sell |
71,745
-16
| -0% | -$37 | 0.03% | 87 |
|
|
2024
Q3 | $254K | Buy |
71,761
+33,784
| +89% | +$120K | 0.05% | 78 |
|
|
2024
Q2 | $105K | Buy |
37,977
+30
| +0.1% | +$83 | 0.02% | 90 |
|
|
2024
Q1 | $252K | Hold |
37,947
| – | – | 0.06% | 77 |
|
|
2023
Q4 | $116K | Buy |
+37,947
| New | +$116K | 0.03% | 98 |
|